831 research outputs found
Debates in the Environmentalist Community: The soy moratorium and the construction of illegal soybeans in the Brazilian Amazon
Soybean production and conversion of tropical forest in the Brazilian Amazon: The case of Vilhena, Rondônia
The recent rise in Brazilian soybean production has generated concern among the environmental community and some authors that natural tropical environments of the Amazon Basin are being converted to soybean fields. Proponents of soybean production counter that soybeans represent a viable agricultural commodity for the region; environmental concern is unwarranted, because new soybean fields are replacing already deforested or otherwise transformed lands. Both arguments have been made without comprehensive study and measure of land-use/land-cover (LULC) in areas undergoing expansion of soybean production. This case study, conducted in the municipality of Vilhena, Rondônia, Brazil, in the southwestern Amazon Basin, uses remote sensing to evaluate the LULC accompanying this municipality's large growth in soybean production from 1996 to 2001. Forests are being converted for soybean production, but most of the production increase appears attributable to slight expansion of already existing fields, conversion of already deforested land, and higher yields
Microscopic Model for Granular Stratification and Segregation
We study segregation and stratification of mixtures of grains differing in
size, shape and material properties poured in two-dimensional silos using a
microscopic lattice model for surface flows of grains. The model incorporates
the dissipation of energy in collisions between rolling and static grains and
an energy barrier describing the geometrical asperities of the grains. We study
the phase diagram of the different morphologies predicted by the model as a
function of the two parameters. We find regions of segregation and
stratification, in agreement with experimental finding, as well as a region of
total mixing.Comment: 4 pages, 7 figures, http://polymer.bu.edu/~hmakse/Home.htm
1FGL J1417.7-4407: A likely gamma-ray bright binary with a massive neutron star and a giant secondary
We present multiwavelength observations of the persistent Fermi-LAT
unidentified gamma-ray source 1FGL J1417.7-4407, showing it is likely to be
associated with a newly discovered X-ray binary containing a massive neutron
star (nearly 2 M_sun) and a ~ 0.35 M_sun giant secondary with a 5.4 day period.
SOAR optical spectroscopy at a range of orbital phases reveals variable
double-peaked H-alpha emission, consistent with the presence of an accretion
disk. The lack of radio emission and evidence for a disk suggests the gamma-ray
emission is unlikely to originate in a pulsar magnetosphere, but could instead
be associated with a pulsar wind, relativistic jet, or could be due to
synchrotron self-Compton at the disk--magnetosphere boundary. Assuming a wind
or jet, the high ratio of gamma-ray to X-ray luminosity (~ 20) suggests
efficient production of gamma-rays, perhaps due to the giant companion. The
system appears to be a low-mass X-ray binary that has not yet completed the
pulsar recycling process. This system is a good candidate to monitor for a
future transition between accretion-powered and rotational-powered states, but
in the context of a giant secondary.Comment: ApJL in pres
Piii‐37
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109838/1/cptclpt2006257.pd
Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography
Characterizing Residue-Bilayer Interactions Using Gramicidin A as a Scaffold and Tryptophan Substitutions as Probes
This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Chemical Theory and Computation, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://doi.org/10.1021/acs.jctc.7b00400.Previous experiments have shown that the lifetime of a gramicidin A dimer channel (which forms from two non-conducting monomers) in a lipid bilayer is modulated by mutations of the tryptophan (Trp) residues at the bilayer-water interface. We explore this further using extensive molecular dynamics simulations of various gA dimer and monomer mutants at the Trp positions in phosphatidylcholine bilayers with different tail lengths. gA interactions with the surrounding bilayer are strongly modulated by mutating these Trp residues. There are three principal effects: eliminating residue hydrogen bonding ability (i.e., reducing the channel-monolayer coupling strength) reduces the extent of the bilayer deformation caused by the assembled dimeric channel; a residue’s size and geometry affects its orientation, leading to different hydrogen bonding partners; and increasing a residue’s hydrophobicity increases the depth of gA monomer insertion relative to the bilayer center, thereby increasing the lipid bending frustration
No Dopamine Agonist Modulation of Brain [F-18]FEOBV Binding in Parkinson's Disease
The[F-18]fluoroethoxybenzovesamicol ([F-18]-FEOBV) positron emission tomography (PET) ligand targets the vesicular acetylcholine transporter. Recent [F-18]FEOBV PET rodent studies suggest that regional brain [F-18]FEOBV binding may be modulated by dopamine D2-like receptor agents. We examined associations of regional brain [F-18]FEOBV PET binding in Parkinson's disease (PD) subjects without versus with dopamine D2-like receptor agonist drug treatment. PD subjects (n = 108; 84 males, 24 females; mean age 68.0 +/- 7.6 [SD] years), mean disease duration of 6.0 +/- 4.0 years, and mean Movement Disorder Society-revised Unified PD Rating Scale III 35.5 +/- 14.2 completed [F-18]FEOBV brain PET imaging. Thirty-eight subjects were taking dopamine D2-like agonists. Vesicular monoamine transporter type 2 [C-11]dihydrotetrabenazine (DTBZ) PET was available in a subset of 54 patients. Subjects on dopamine D2-like agonists were younger, had a longer duration of disease, and were taking a higher levodopa equivalent dose (LED) compared to subjects not taking dopamine agonists. A group comparison between subjects with versus without dopamine D2-like agonist use did not yield significant differences in cortical, striatal, thalamic, or cerebellar gray matter [F-18]FEOBV binding. Confounder analysis using age, duration of disease, LED, and striatal [C-11]DTBZ binding also failed to show significant regional [F-18]FEOBV binding differences between these two groups. Chronic D2-like dopamine agonist use in PD subjects is not associated with significant alterations of regional brain [F-18]FEOBV binding
- …